Who is sponsoring NCT03856190?

NCT03856190 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT03856190?

Interventions in NCT03856190: Fasting and plant-based nutrition, Standard Nutrition Counselling.

What condition does NCT03856190 study?

NCT03856190 studies Rheumatoid Arthritis.

Is NCT03856190 still recruiting?

NCT03856190 is currently terminated. Last updated 7 February 2022.

Last reviewed 2022-02-07 · How we verify

NCT03856190: NutriFast

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Therapeutic Fasting and Specific Diet in Patients With Rheumatoid Arthritis

Terminated NA Last updated 7 February 2022

What this trial tests

NA trial testing Fasting and plant-based nutrition in Rheumatoid Arthritis in 53 participants. Terminated before completion.

Timeline

18 March 2019

Primary endpoint
8 April 2021

7 July 2021

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	53
Start date	18 March 2019
Primary completion	8 April 2021
Estimated completion	7 July 2021
Sites	2 locations across Germany

Drugs / interventions tested

Fasting and plant-based nutrition
Standard Nutrition Counselling

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 18 to 70, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this trial is an evaluation of the effectiveness of fasting and a subsequent diagnosis-specific diet change in patients with rheumatoid arthritis in respect to improving rheumatic symptoms and further to investigate possible mechanisms of this improvement.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

To eat or not to eat-an exploratory randomized controlled trial on fasting and plant-based diet in rheumatoid arthritis (NutriFast-Study).
Hartmann AM, Dell'Oro M, Spoo M, Fischer JM, et al · · 2022 · cited 22× · PMID 36407522 · DOI 10.3389/fnut.2022.1030380
Role of Sirtuins in the Pathogenesis of Rheumatoid Arthritis.
Poniewierska-Baran A, Bochniak O, Warias P, Pawlik A. · · 2023 · cited 14× · PMID 36675041 · DOI 10.3390/ijms24021532
Efficacy of therapeutic fasting and plant-based diet in patients with rheumatoid arthritis (NutriFast): study protocol for a randomised controlled clinical trial.
Hartmann AM, Dell'Oro M, Kessler CS, Schumann D, et al · · 2021 · cited 11× · PMID 34380725 · DOI 10.1136/bmjopen-2020-047758
Post Hoc Analysis of a Randomized Controlled Trial on Fasting and Plant-Based Diet in Rheumatoid Arthritis (NutriFast): Nutritional Supply and Impact on Dietary Behavior.
Hartmann AM, D'Urso M, Dell'Oro M, Koppold DA, et al · · 2023 · cited 7× · PMID 36839208 · DOI 10.3390/nu15040851

Verify or expand the search:

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03856190 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 7 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03856190.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing